|
[1]
|
李鹏, 王拥军, 陈光勇, 等. 中国早期结直肠癌及癌前病变筛查与诊治共识[J]. 中国实用内科杂志, 2015, 35(3): 211-227.
|
|
[2]
|
Li, R., Liu, J., Xue, H., et al. (2012) Diagnostic Value of Fecal Tumor M2-Pyruvate Kinase for CRC Screening: A Systematic Review and Meta-Analysis. International Journal of Cancer, 131, 1837-1845. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Potack, J. and Itzkowitz, S.H. (2010) Practical Advances in Stool Screening for Colorectal Cancer. Journal of the National Comprehensive Cancer Network, 8, 81-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Lindholm, E., Brevinge, H. and Haglind, E. (2008) Survival Benefit in a Randomized Clinical Trial of Faecal Occult Blood Screening for Colorectal Cancer. The British Journal of Surgery, 95, 1029-1036. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhu, M.M., Xu, X.T., Nie, F., et al. (2010) Comparison of Immunochemical and Guaiacbased Fecal Occult Blood Test in Screening and Surveillance for Advanced Colorectal Neoplasms: A Meta-Analysis. Journal of Digestive Diseases, 11, 148-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lane, J.M., Chou, W., Young, G.P., et al. (2010) Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal Neoplasia. Gastroenterology, 139, 1918-1926. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Faivre, J., Dancourt, V. and Lejeune, C. (2012) Screening for Colorectal Cancer with Immunochemical Faecal Occult Blood Tests. Digestive and Liver Disease, 44, 967-973. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Morikawa, T., Kato, J., Yamaji, Y., et al. (2005) A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonos Copy in the a Symptomatic Population. Gastroenter-ology, 129, 422-428. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Allison, J.E., Sakoda, L.C., Levin, T.R., et al. (2007) Screening for Colorectal Neoplasms with New Fecal Occult Blood Tests: Update on Perform an Cecharacteristics. Journal of the National Cancer Institute, 99, 1462-1470.
|
|
[10]
|
Miyoshi, H., Oka, M., Sugi, K., et al. (2000) Accuracy of Detection of Colorectal Neoplasia Using an Immunochemical Occult Blood Test in Symptomatic Referred Patients: Comparison of Retrospective and Prospective Studies. Internal Medicine, 39, 701-706. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hirata, I., Hoshimoto, M., Saito, O., et al. (2007) Usefulness of Fecal Lactoferrin and Hemoglobin in Diagnosis of Colorectal Diseases. World Journal of Gastroenterology, 13, 1569-1574. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sheng, J.Q., Li, S.R., Wu, Z.T., et al. (2009) Transferrin Dipstick as a Potential Novel Test for Colon Cancer Screening : A Comparative Study With Immuno Fecal Occult Blood Test. Cancer Epidemiology, Biomarkers & Prevention, 18, 2182-2185. [Google Scholar] [CrossRef]
|
|
[13]
|
Chen, J.G., Cai, J., Wu, H.L., et al. (2012) Colorectal Cancer Screening: Comparison of Transferrin and Immuno Fecal Occult Blood Test. World Journal of Gastroenterology, 18, 2682-2688. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Osborn, N.K. and hlquist, D.A. (2005) Stool Screening for Colorectal Cancer: Molecular Approaches. Gastroenterology, 128, 192-206. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Liu, Y., He, G., Wang, Y., et al. (2013) MCM-2 Is a Therapeutic Target of Trichostatin A in Colon Cancer Cells. Toxicology Letters, 221, 23-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wei, Q., Li, J., Liu, T., et al. (2013) Phosphorylation of Mini-chromosome Maintenance Protein 7 (MCM7) by Cyclin/Cyclin-Dependent Kinase Affects Its Function in Cell Cycle Regulation. Journal of Biological Chemistry, 288, 19715-19725. [Google Scholar] [CrossRef]
|
|
[17]
|
Davies, R.J., Freeman, A., Morris, L.S., et al. (2002) Analysis of Minichromosome Maintenance Proteins as a Novel Method for Detection of Colorectal Cancer in Stool. The Lancet, 359, 1917-1919. [Google Scholar] [CrossRef]
|
|
[18]
|
Yiu, A.J. and Yiu, C.Y. (2016) Biomarkers in Colorectal Cancer. Anticancer Research, 36, 1093-1102.
|
|
[19]
|
Gerrits, M.M., Chen, M., Theeuwes, M., et al. (2011) Bi-omarker-Based Prediction of Inflammatory Bowel Disease-Related Colorectal Cancer: A Case Control Study. Cellular Oncology, 34, 107-117. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Dewhurst, S.M., Mcgranahan, N., Burrell, R.A., et al. (2014) Tolerance of Whole Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution. Cancer Discovery, 4, 175-185. [Google Scholar] [CrossRef]
|
|
[21]
|
Brennan, C.W., Verhaak, R.G., Mckenna, A., et al. (2013) The Somatic Genomic Landscape of Glioblastoma. Cell, 155, 462-477. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Thompson, S.L. and Compton, D.A. (2010) Proliferation of An-euploid Human Cells Is Limited by a p53-Dependent Mechanism. The Journal of Cell Biology, 188, 369-381. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kanthan, R., Senger, J.L. and Kanthan, S.C. (2012) Fecal Molecular Markers for Colorectal Cancer Screening. Gastroenterology Research and Practice, 2012, Article ID: 184343.
|
|
[24]
|
Davies, R.J., Miller, R. and Coleman, N. (2005) Colorectal Cancer Screening: Prospects for Molecular Stool Analysis. Nature Reviews Cancer, 5, 199-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Levin, B. (2006) Mo-lecular Screening Testing for Colorectal Cancer. Clinical Cancer Research, 12, 5014-5017. [Google Scholar] [CrossRef]
|
|
[26]
|
Zou, H., Allawi, H., Cao, X., et al. (2012) Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology. Clinical Chemistry, 58, 375-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lidgard, G.P., Domanico, M.J., Bruinsma, J.J., et al. (2013) Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal Neoplasia. Clinical Gastroenter-ology and Hepatology, 11, 1313-1318. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., et al. (2014) Multitarget Stool DNA Testing for Colorectal-Cancer Screening. The New England Journal of Medicine, 370, 1287-1297. [Google Scholar] [CrossRef]
|
|
[29]
|
Bosch, L.J.W., Carvalho, B., Fijneman, R.J.A., Jimenez, C.R., et al. (2011) Molecular Tests for Colorectal Cancer Screening. Clinical Colorectal Cancer, 10, 8-23. [Google Scholar] [CrossRef]
|
|
[30]
|
Takai, T., Kanaoka, S., Yoshida, K., et al. (2009) Fecal Cyclooxy-genase2 plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal? Cancer Screening. Cancer Epide-miology, Biomarkers & Prevention, 18, 1888-1893.
|
|
[31]
|
Lagerholm, S., Dutta, S. and Nair, P. (2005) Non-Invasive Detection of c-myc p64, c-myc p67 and c-erbb-2 in Colorectal Cancer. Scandinavian Journal of Gastroenterology, 40, 1343-1350. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Ahmed, F.E., Jeffries, C.D., Vos, P.W., et al. (2009) Diagnostic microRNA Markers for Screening Sporadic Human Colon Cancer and Active Ulcerative Colitis in Stool and Tissue. Cancer Genomics Proteomics, 6, 281-295.
|
|
[33]
|
Qimye, I.K. (2008) Haptoglobin, Inflammation and Disease. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102, 735-742. [Google Scholar] [CrossRef] [PubMed]
|